{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:46:39Z","timestamp":1784191599044,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.jaci.2006.01.041","type":"journal-article","created":{"date-parts":[[2006,4,21]],"date-time":"2006-04-21T21:36:22Z","timestamp":1145655382000},"page":"865-869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Gene therapy for immune disorders: Good news tempered by bad news"],"prefix":"10.1016","volume":"117","author":[{"given":"Jennifer M.","family":"Puck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L.","family":"Malech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2006.01.041_bib1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1034\/j.1600-065X.2002.18517.x","article-title":"Primary immunodeficiency disease: dissectors of the immune system","volume":"185","author":"Buckley","year":"2002","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2006.01.041_bib2","series-title":"Primary immunodeficiency diseases, a molecular and genetic approach","first-page":"99","article-title":"X-linked severe combined immunodeficiency","author":"Puck","year":"1999"},{"key":"10.1016\/j.jaci.2006.01.041_bib3","first-page":"111","article-title":"T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency","volume":"48","author":"Smogorzewska","year":"2000","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.jaci.2006.01.041_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","article-title":"Long-term survival and transplantation of hematopoietic stem cells for immunodeficiencies: report of the European experience 1968-1999","volume":"361","author":"Antoine","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2006.01.041_bib5","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1046\/j.1365-2141.2003.04390.x","article-title":"Risks of mortality in children admitted to the paediatric intensive care unit after haematopoietic stem cell transplantation","volume":"121","author":"Tomaske","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2006.01.041_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199902183400703","article-title":"Hematopoietic stem cell transplantation for the treatment of severe combined immunodeficiency","volume":"340","author":"Buckley","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2006.01.041_bib7","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM200005043421804","article-title":"Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency","volume":"342","author":"Patel","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2006.01.041_bib8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood.V99.3.872","article-title":"Hematopoietic stem cell transplantation for SCID in the neonatal period leads to superior thymic output and improved survival","volume":"99","author":"Myers","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2006.01.041_bib9","unstructured":"Hay BN, Puck JM, Uzel G, Davis J, Hsu AP, Linton G. Absence of B-cell, NK-cell myeloid or CD34 cell engraftment in some X-linked severe combined immunodeficiency (XSCID) patients following haploidentical transplant. Abstract presented at: American Society of Hematology Annual Meeting, Philadelphia (PA), December 6-10, 2002."},{"key":"10.1016\/j.jaci.2006.01.041_bib10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jaci.2006.01.041_bib11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa012616","article-title":"Sustained correction of X-linked severe combined immunodeficiency by ex-vivo gene therapy","volume":"346","author":"Hacein-Bey-Abina","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2006.01.041_bib12","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.270.5235.470","article-title":"Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients","volume":"270","author":"Bordignon","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jaci.2006.01.041_bib13","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with non-myeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaci.2006.01.041_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaci.2006.01.041_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1016\/j.jaci.2006.01.041_bib16","first-page":"1794s","article-title":"The effect of chromosomal translocations in acute leukemias: the LMO2 paradigm in transcription and development","volume":"59","author":"Rabbitts","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaci.2006.01.041_bib17","doi-asserted-by":"crossref","first-page":"60a","DOI":"10.1182\/blood.V106.11.195.195","article-title":"Gene therapy for severe combined immunodeficiency X1","volume":"106","author":"Hacein-Bey-Abina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2006.01.041_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4889(03)00024-7","article-title":"Current developments in the design of onco-retrovirus and lentivirus vector systems for hematopoietic cell gene therapy","volume":"1640","author":"Brenner","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2006.01.041_bib19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1084\/jem.176.4.1125","article-title":"Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer","volume":"176","author":"Donahue","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2006.01.041_bib20","first-page":"629","article-title":"American Society of Gene Therapy\u2014Eighth Annual Meeting","volume":"8","author":"Vandendriessche","year":"2005","journal-title":"IDrugs"},{"key":"10.1016\/j.jaci.2006.01.041_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.1068893","article-title":"Murine leukemia induced by retroviral gene marking","volume":"296","author":"Li","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaci.2006.01.041_bib22","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1182\/blood-2005-03-1115","article-title":"Recurrent retroviral vector integration at the Mds1\/Evi1 locus in nonhuman primate hematopoietic cells","volume":"106","author":"Calmels","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2006.01.041_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1126\/science.1091667","article-title":"Gene therapy insertional mutagenesis insights","volume":"303","author":"Dave","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jaci.2006.01.041_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jaci.2004.01.764","article-title":"A historical view of bone marrow transplants for immunodeficiencies","volume":"113","author":"Buckley","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.01.041_bib25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2004.10.012","article-title":"Development of population-based newborn screening for severe combined immunodeficiency","volume":"115","author":"Chan","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.01.041_bib26","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.1083413","article-title":"Transcription start regions in the human genome are favored targets for MLV integration","volume":"300","author":"Wu","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaci.2006.01.041_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","article-title":"HIV-1 integration in the human genome favors active genes and local hotspots","volume":"110","author":"Schroder","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2006.01.041_bib28","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1182\/blood.V99.6.1902","article-title":"Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene","volume":"99","author":"May","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2006.01.041_bib29","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1128\/JVI.74.10.4679-4687.2000","article-title":"The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration","volume":"74","author":"Rivella","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2006.01.041_bib30","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1073\/pnas.160159597","article-title":"A chromatin insulator protects retrovirus vectors from chromosomal position effects","volume":"97","author":"Emery","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2006.01.041_bib31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature03556","article-title":"Highly efficient endogenous human gene correction using designed zinc-finger nucleases","volume":"435","author":"Urnov","year":"2005","journal-title":"Nature"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674906002995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674906002995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:03:37Z","timestamp":1758776617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674906002995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0091674906002995"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2006.01.041","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy for immune disorders: Good news tempered by bad news","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2006.01.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}